Abstract
Autophagosomes are formed during autophagy, which is activated by hypoxia and starvation. Autophagy is important for mast cell degranulation. We hypothesized that autophagy is a key feature in the pathogenesis of systemic sclerosis (SSc). We examined SSc clinical features and mast cell density across the presence and severity of autophagy. Skin punch biopsy was performed on 33 SSc patients and 6 healthy controls (HC). Autophagy was evaluated by immunofluorescence on paraffin sections using LC3-FITC staining on these patients. The intensity of staining and mast cell density was examined across clinical features in 19 of the SSc patients. Presence of autophagosome formation was assessed by EM in 17 of the SSc patients and 4 HC. In our SSc study population, 29 of subjects were female and 23 were limited cutaneous. Twenty-nine of 33 SSc patients had autophagy by LC3-FITC staining. Intensity of staining decreased with longer duration of SSc (p = 0.09) and RP (p = 0.10). Bloating and distention differed across level of intensity staining (Wilcoxon signed-rank test, p = 0.05), with the greatest levels among those with moderate intensity. On EM, autophagosome formation was present in 16 of 17 SSc patients and no HC. All SSc patients had perivascular mast cells. Autophagy was present in 29 of 33 SSc patients, and none of our HC suggesting importance in pathogenesis. Autophagy staining was greater among those with shorter duration of SSc. Bloating and distention were higher in patients with moderate autophagy staining. Perivascular mast cells were present in all SSc patients. The role of autophagy in vasculopathy and mast cell activation in SSc warrants further studies.
This is a preview of subscription content, log in via an institution to check access.
Abbreviations
- SSc:
-
Systemic sclerosis
- HC:
-
Healthy control
- EM:
-
Electron microscopy
- RP:
-
Raynaud’s phenomenon
- mRSS:
-
Modified Rodnan skin score
- BMI:
-
Body mass index
References
Frech T, Khanna D, Markewitz B, Mineau G, Pimentel R, Sawitzke A (2010) Heritability of vasculopathy, autoimmune disease, and fibrosis in systemic sclerosis: a population-based study. Arthr Rheum 62:2109–2116
Martin JE, Broen JC, Carmona FD et al (2012) Identification of CSK as a systemic sclerosis genetic risk factor through genome wide association study follow-up. Hum Mol Genet 21:2825–2835
Sargent JL, Whitfield ML (2011) Capturing the heterogeneity in systemic sclerosis with genome-wide expression profiling. Expert Rev Clin Immunol 7:463–473
Gyger G, Baron M (2012) Gastrointestinal manifestations of scleroderma: recent progress in evaluation, pathogenesis, and management. Curr Rheumatol Rep 14:22–29
Razykov I, Thombs BD, Hudson M, Bassel M, Baron M (2009) Prevalence and clinical correlates of pruritus in patients with systemic sclerosis. Arthr Rheum 61:1765–1770
Matucci-Cerinic M, Czirjak L (2009) Immune-endothelial-nerve interaction: an explanation for the failure of the gastrointestinal system in systemic sclerosis? Ann Rheum Dis 68:609–610
Murtaugh MA, Frech TM (2013) Nutritional status and gastrointestinal symptoms in systemic sclerosis patients. Clin Nutr 32(1):130–135
Frech TM, Revelo MP, Drakos SG et al (2012) Vascular leak is a central feature in the pathogenesis of systemic sclerosis. J Rheumatol 39:1385–1391
Frieri M (1992) Systemic sclerosis. The role of the mast cell and cytokines. Ann Allergy 69:385–392, 95–96
Hawkins RA, Claman HN, Clark RA, Steigerwald JC (1985) Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis? Ann Intern Med 102:182–186
Claman HN (1989) Mast cell changes in a case of rapidly progressive scleroderma-ultrastructural analysis. J Invest Dermatol 92:290–295
Sigal LH (2011) Basic science for the clinician 52: adipokines. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis 17:157–161
Ng MF (2010) The role of mast cells in wound healing. Int Wound J 7:55–61
Reggiori F, Klionsky DJ (2002) Autophagy in the eukaryotic cell. Eukaryot Cell 1:11–21
Cuervo AM, Bergamini E, Brunk UT, Droge W, Ffrench M, Terman A (2005) Autophagy and aging: the importance of maintaining “clean” cells. Autophagy 1:131–140
Ushio H, Ueno T, Kojima Y et al (2011) Crucial role for autophagy in degranulation of mast cells. J Allergy Clin Immunol 127(1267–76):e6
Del Principe D, Vona R, Giordani L, Straface E, Giammarioli AM (2011) Defective autophagy in fibroblasts may contribute to fibrogenesis in autoimmune processes. Curr Pharm Des 17:3878–3887
Castello-Cros R, Whitaker-Menezes D, Molchansky A et al (2011) Scleroderma-like properties of skin from caveolin-1-deficient mice: implications for new treatment strategies in patients with fibrosis and systemic sclerosis. Cell Cycle 10:2140–2150
(1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthr Rheum 23:581–90
Rubinsztein DC, DiFiglia M, Heintz N et al (2005) Autophagy and its possible roles in nervous system diseases, damage and repair. Autophagy 1:11–22
Debnath J, Baehrecke EH, Kroemer G (2005) Does autophagy contribute to cell death? Autophagy 1:66–74
Weiner LM, Lotze MT (2012) Tumor-cell death, autophagy, and immunity. New Engl J Med 366:1156–1158
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Frech, T., De Domenico, I., Murtaugh, M.A. et al. Autophagy is a key feature in the pathogenesis of systemic sclerosis. Rheumatol Int 34, 435–439 (2014). https://doi.org/10.1007/s00296-013-2827-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-013-2827-8